Institutional Centers for Clinical and Translational Research (ICCTR)





ICCTR | Funding | Underrepresented in Medicine Faculty Clinical Research Grant

Deadlines and deliverables

Call for proposals: May 26, 2021
Grant submission deadline: July 15, 2021
Grant award decisions announced: August 1, 2021
Grant funding period begins: September 1, 2021
Grant progress reports due: March 2022, September 2022, March 2023
Boston Children’s Hospital Research presentation: May 2023
Grant final report due: June 30, 2023

Download the application instructions.

Questions: Please contact either Dr. Lise Nigrovic at lise.nigrovic@childrens.harvard.edu or Dr. Valerie L. Ward at valerie.ward@childrens.harvard.edu

Program description

The Institutional Centers for Clinical and Translational Research (ICCTR), in collaboration with the Office of Health Equity and Inclusion and the Office of Faculty Development, announces the 2021 Underrepresented in Medicine (UiM) Faculty Clinical Research Grant. At Boston Children’s Hospital (BCH), and in alignment with our hospital’s Declaration on Equity, Diversity and Inclusivity, we are committed to expanding underrepresentation of researchers from diverse population groups in the clinical research setting. This is fundamental for creating a more inclusive environment and capitalizing on innovative ideas.

Encouraging the research careers of early career faculty from diverse backgrounds and life experiences is important as they bring different perspectives to solve complex clinical research problems. A diverse scientific workforce at BCH will enable us to continue fostering scientific innovation, improving the quality of the research, and contributing to robust learning environments. , this call for proposals is focused on Instructors or Assistant Professors from underrepresented in medicine groups. Clinical research projects with a focus on promoting health equity and reducing disparities are encouraged; however, this is not a requirement for funding.

Purpose of award

The ultimate purpose of this two-year grant is to enhance Boston Children’s Hospital commitment to achieving a culture honoring equity, diversity, respect, inclusion and excellence.

Funding

The total award is $50,000 per year for two years ($100,000 total). The funding period will be from September 1, 2021 to August 30, 2023 and can be used toward the following:

  • $25,000/year ($50,000 total) for any budget category
  • $25,000/year ($50,000 total) for a clinical research project manager or a study coordinator
  • The applicant’s division/department must commit to support an additional 20% of the investigator’s time to conduct the proposed research.

Eligibility

The applicant must have either an MD and/or PhD (or equivalent) as well as a current primary academic appointment at Boston Children’s Hospital (i.e., receiving salary/benefits from BCH or a foundation) with a Harvard Medical School Instructor or Assistant Professor appointment as of July 1, 2021, and from the following racial and ethnic groups that have been defined by the National Institutes of Health (NIH) as underrepresented in biomedical research: Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, Native Hawaiians, and other Pacific Islanders. The applicant should also have demonstrated excellence in research training, productivity, and a well-defined focus in clinical or translational but without substantial independent support. Applicants on training grants are encouraged to apply. 

Not eligible to apply are faculty,

  • who have received a BTREC/CTREC recruitment package within the past 4 years
  • with a fundable score on their R01 application
  • who are current recipients of any Boston Children’s Hospital faculty development award

Application format requirements

Applications must include:

  • Face page: principal investigator’s name and project title; BCH ID number; Division/Department/Program, Children’s Hospital professional and Harvard Medical School academic professional appointments; email; Type of research: Clinical and/or Translational
  • Clinical research proposal summary (3-page limit, excluding references): background and significance; aims and hypotheses; preliminary data; methods; analysis plan; timeframe; and references. Clinical research protocol if applicable and approved by IRB.
  • Career Development Plan (½ page limit)
  • NIH Biosketch and Other support (NIH format) if applicable. Include all current and pending funding with committed effort.
  • Budget and Budget Justification: Budget (see budget template) should not exceed $50,000 direct costs/year for two years. Please identify what award money will be used for (e.g., your salary, salary of a Clinical Research project manager or study coordinator, supplies) using the provided budget form. Salaries should be expressed as a percent effort and can include fringe benefits. If you have funding from other sources, please outline how these additional funding sources will be utilized.
  • Department/Division/Program Chair Letter and Attestation: The chair letter should describe support of the applicant’s career and potential for academic advancement at BCH. This letter must include a commitment to providing 20% of the total direct and indirect costs of the salary plus fringe of the applicant should the proposal be awarded. The division chief should also sign the attestation that the applicant will be given dedicated time to complete this research effort.
  • Clinical Research Mentor: Include a letter of support from the applicant’s research mentor (if different from Department/Division/Program Chair) in support of applicant’s career and “path to independence.”

Proposal submission and review

  • Application materials should be submitted using this link http://s.alchemer.com/s3/UIM-RFA
  • All proposals will be evaluated and ranked by an ad hoc review panel, consisting of BCH investigators. The review committee may choose to interview potential recipients. Criteria for funding priority for all applications will be: excellence of clinical research design, need, and promise for future funding and academic advancement. The awards will be announced by email following the review process and final approval by ICCTR, Office of Health Equity and Inclusion and the Office of Faculty Development.

*All funded project deliverables must contain the following acknowledgement, “Funding for the project was in part obtained from the Institutional Centers for Clinical and Translational Research (ICCTR) and Harvard Catalyst, and in a collaboration with the Boston Children’s Office of Health Equity and Inclusion and Office of Faculty Development.”

UiM review committee

  • Lise Nigrovic, MD, MPH (Chair)
  • Patrice Melvin, MPH (statistical reviewer)
  • S. Jean Emans, MD (career development reviewer)
  • Hernan Santana, MS (budget reviewer)
  •  John Fiadjoe, MD
  • Snehal N. Shah, MD
  • Sabra L. Katz-Wise, PhD
  • Valerie L. Ward, MD, MPH
  • Lois K. Lee, MD, MPH
 

 

 

Enid Martinez ICCTR Funding Recipient

Enid Martinez, MDIn collaboration with the Office of Health Equity and Inclusion and the Office of Faculty Development, the ICCTR is pleased to announce Enid E. Martinez, MD, is the recipient of the 2021 Underrepresented in Medicine (UiM) Faculty Clinical Research Grant. Dr. Martinez’s project, "Examining the role of zonulin in gastric dysmotility in critical illness," will significantly expand the knowledge in the area of gastric motility and inform therapies for these critically ill children. With this award, Dr. Martinez will receive two years of support.

This research funding opportunity was developed by the Office of Health Equity and Inclusion and the Office of Faculty Development and supported financially by ICCTR/Harvard Catalyst for junior faculty who belong to a racial/ethnic population underrepresented in medicine (UiM) and science.

 

 

The commitment and compassion with which we care for all children and families is matched only by the pioneering spirit of discovery and innovation that drives us to think differently, to find answers, and to build a better tomorrow for children everywhere.

Kevin B. Churchwell, President and CEO